For the fourth year in a row, the University of California San Diego has been ranked by Times Higher Education the world’s number one university founded during the “Golden Age” of higher education.
UC San Diego researchers have discovered that a single treatment to inhibit a gene called PTB in mice converts native astrocytes, brain support cells, into neurons that produce the neurotransmitter dopamine. As a result, the mice’s Parkinson’s disease symptoms disappear.
The Sherlock Division of SDSC has broadened its secure Cloud solutions portfolio to offer Skylab, an innovative customer-owned Cloud platform solution that provides a self-standing, compliant environment for secure workloads in the Amazon Web Services (AWS) Cloud.
A team of engineers and physicians at the University of California San Diego has developed a low-cost, easy-to-use emergency ventilator for COVID-19 patients that is built around a ventilator bag usually found in ambulances.
UC San Diego researchers uncovered in mice how IRE1α, a molecule involved in cells’ response to stress, determines whether macrophages promote inflammation in the tumor microenvironment. Inflammation is known to promote tumor growth, making IRE1α an attractive target for drug development.
Because of silicon’s relatively high cost, hybrid organic-inorganic perovskites (HOIPs) have emerged as a lower-cost and highly efficient option for solar power, according to a study by Georgia Institute of Technology researchers.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
